Acorda Therapeutics Stock News

The rollout of anti-coronavirus drug, remdesivir will take more time as pharmaceutical firms are working on providing safety and quality data for its production. The Union Health Ministry has recommen

Remdesivir, the investigational drug from Gilead Sciences Inc, has been issued an 'emergency use authorisation' (EUA) by the United States Food and Drug Administration (USFDA) to treat patients suffer

Drug firm Zydus Cadila on Friday said it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distribution of remdesivir, a potential therapy for COVID-19.

Teladoc (TDOC) continues to benefit from constant top-line growth and strategic initiatives, which have been aiding its share price.

The much-touted anti-malarial drug hydroxychloroquine will continue to be used while azythromycin may be dropped from the treatment protocol, sources in the know of the developments told PTI.

Anti-viral drug remdesivir and tocilizumab, an immunomodulator, are being considered for 'restricted use' on severely ill COVID-19 patients on 'emergency and compassionate grounds', according to revis

The much-touted anti-malarial drug hydroxychloroquine will continue to be used while azythromycin may be dropped from the treatment protocol

Investors need to pay close attention to Acorda Therapeutics (ACOR) stock based on the movements in the options market lately.

Maharashtra Health Minister Rajesh Tope on Saturday said that the state will procure 10,000 vials of Remdesivir drug.

Abiomed (NASDAQ: ABMD) announces the United States Food and Drug Administration (FDA) has approved the company's investigational device exemption appl

Acorda (ACOR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of India (DCGI) to seek its approval to manufacture and se

While there is a huge interest in Covid-19 vaccine candidates, therapeutics are also an immediate need and will still be greatly in demand even after vaccines a

Acadia Healthcare (ACHC) partners with Covenant Health for offering improved mental health services in East Tennessee.